Claudia Lommatzsch | Medicine and Health Sciences | Visionary Research Award 2971

Published on 23/12/202526/12/2025 by Research Hypothesis

Dr. Claudia Lommatzsch | Medicine and Health Sciences | Visionary Research Award

Dr. Claudia Lommatzsch | Medicine and Health Sciences | Senior Physician | St. Franziskus-Hospital | Germany

Dr. Claudia Lommatzsch is a distinguished clinician-scientist in ophthalmology, recognized for her significant contributions to glaucoma diagnostics, ocular imaging, and translational vision research. She received her medical education from a leading German medical university and later achieved advanced academic qualification through habilitation, reflecting her expertise in independent research and university-level teaching. Professionally, Dr. Claudia Lommatzsch has built a strong career as a senior physician and researcher within a major ophthalmology department, where she seamlessly integrates clinical responsibilities with innovative research activities. Her professional experience spans patient-centered glaucoma care, advanced imaging diagnostics, and interdisciplinary research collaborations that connect clinical ophthalmology with laboratory-based biomarker analysis. Her primary research interests include glaucoma pathophysiology, optical coherence tomography, OCT angiography, vascular and molecular biomarkers, pediatric ocular imaging, and disease progression assessment, with a particular emphasis on improving early diagnosis and personalized treatment strategies. In the middle of her academic career trajectory, she has authored 28 documents, accumulated 316 citations, and achieved an h-index of 8, demonstrating measurable scientific impact and consistent research productivity within indexed international journals.

Citation Metrics (Scopus)

500

400

300

200

100

Citations316

i10index28

h-index8

🟦 Citations 🟥 Documents 🟩 h-index

View scopus Profile
View ORCID Profile

Featured Publications

ET-1, MMPs, ZAG, and APN Link Reduced Ocular Perfusion to Glaucoma

– Biomolecules, Open Access

Assessment of Chronic Degenerative Eye Disease Progression

– Editorial, Open Access

Sheeja Sheela Rajan | Biology and Life Sciences | Best Researcher Award

Published on 25/04/202525/04/2025 by Research Hypothesis

Sheeja Sheela Rajan | Biology and Life Sciences | Best Researcher Award

Dr Sheeja Sheela Rajan, University of Johannesburg, South Africa

Dr. Sheeja Sheela Rajan is a distinguished biochemist with extensive experience in venom pharmacology, molecular biology, and neurobehavioral research. She earned her Ph.D. in Biochemistry from Manonmaniam Sundaranar University, where her thesis on Bungarus caeruleus venom received high acclaim. Currently, she serves as a Postdoctoral Fellow at the Laser Research Centre, University of Johannesburg. Her research spans enzyme purification, coagulation mechanisms, clock gene regulation, and stress neurobiology using Drosophila melanogaster as a model. Dr. Rajan has held academic leadership roles and has taught biochemistry across reputed institutions in India. She is a prolific author, with several peer-reviewed publications in international journals. Passionate about bridging traditional biochemistry with modern biomedical science, she continues to contribute to global health and toxicology. Her achievements and dedication to research excellence make her a strong candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Dr. Sheeja Sheela Rajan completed her Ph.D. in Biochemistry (2010–2015) from Manonmaniam Sundaranar University, Tamil Nadu, India. Her doctoral work focused on the “Pharmacological characterization and purification of dominant enzymes from Bungarus caeruleus venom for coagulation and hemotoxic studies,” earning her high praise and official award in September 2015. She holds an M.Sc. in Biochemistry (2007–2009) from Malankara College, Tamil Nadu, where she investigated “DAZ-1 expression in azoospermic males.” Her strong academic foundation blends molecular biology, enzymology, and toxicology, laying the groundwork for a career in both research and academia. Her interdisciplinary education reflects her ability to integrate classical biochemistry techniques with innovative approaches in behavioral and venom-based biomedical research.

Experience

Dr. Rajan is currently a Postdoctoral Fellow at the Laser Research Centre, Faculty of Health Science, University of Johannesburg (2023–present), exploring stress response and neurobehavior in Drosophila. She previously served as a Postdoctoral Fellow at Annamalai University (2018–2021), researching venom pharmacology and biochemical mechanisms. Her academic career includes roles as Assistant Professor and Head of the Department at Excel College for Commerce and Science (2022–2023) and Dean of Student Affairs at Thievanai Ammal College for Women (2015–2018). Her research journey began as a Research Scholar at Manonmaniam Sundaranar University (2010–2015) and Malankara Catholic College (2007–2009). Dr. Rajan combines academic leadership with experimental expertise in toxicology, molecular biology, and behavioral science.

Awards and Honors

Dr. Rajan was awarded a Postdoctoral Fellowship at Annamalai University (2018–2021) in recognition of her advanced research in biochemistry and venom pharmacology. Her Ph.D. thesis received high commendation for its innovative exploration of hemotoxic enzymes in Bungarus caeruleus venom. She has presented her work at prestigious international and national conferences, including those on biodiversity, chronobiology, and optics. A respected member of the Indian Society for Biological Chemists and the Indian Biochemical Society, she actively contributes to academic discussions and interdisciplinary collaboration. Dr. Rajan’s excellence in teaching and research has earned her recognition in multiple roles, including department head and dean, highlighting her dedication to student mentorship and scientific innovation.

Research Focus

Dr. Sheeja Sheela Rajan’s research bridges venom pharmacology, molecular biology, and neurobehavioral science. Her doctoral research explored the purification and characterization of venom enzymes from Bungarus caeruleus, focusing on their effects on coagulation and hemotoxic pathways. Her postdoctoral work investigates clock genes, stress regulation, and circadian rhythm modulation using Drosophila melanogaster. She studies how food deprivation influences sleep, memory, and sensory responses in fruit flies, using venom components and phenolic compounds to track behavioral and anti-stress responses. Her interest in biochemical pathways conserved between humans and flies positions her research at the forefront of translational studies. With a robust background in toxicology, PCR, cell culture, fluorescence microscopy, and animal models, she contributes significantly to both fundamental and applied biomedical sciences.

Publication Top Notes

Breaking the Resistance: Photodynamic Therapy in Cancer Stem Cell-Driven Tumorigenesis

Advancing Photodynamic Therapy with Nano-Conjugated Hypocrellin: Mechanisms and Clinical Applications

Overcoming challenges in cancer treatment: Nano‐enabled photodynamic therapy as a viable solution

SNAKE VENOM-DERIVED PEPTIDES AS PROSPECTIVE PHARMACOLOGICAL TOOLS: RECENT TRENDS

Biological clock and carcinogenesis: role of <i>Lobophora variegata</i> extract on liver cancer

Multidrug Resistance for Cancer Treatment: Delivery of Ursolic Acid and Caffeine by Poly (Lactic-Co-Glycolic Acid) Nanoparticles

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Published on 16/04/202516/04/2025 by Research Hypothesis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences 🧠🔬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 🎓🇨🇳. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery 🏥🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 🎓🔍. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery 📚. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being ❤️‍🩹.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital 🏥. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery 👨‍⚕️. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University 🎓. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease 📚🔬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) 🧑‍🔬🏅. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) 🇨🇳🔍. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) 💡🔬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes 🧪📊. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions 💊🧠🧑‍⚕️.

Publication Top Notes

Annexin A1 regulates inflammatory-immune response and reduces pancreatic and extra- pancreatic injury during severe acute pancreatitis

Translating CD47-Targeted Therapy in Gastrointestinal Cancers: Insights from Preclinical to Clinical Studies

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway

High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer

Hafiz Muhammad Ali | Biology and Life Sciences | Best Researcher Award

Published on 13/03/202513/03/2025 by Research Hypothesis

Hafiz Muhammad Ali | Biology and Life Sciences | Best Researcher Award

Assist. Prof. Dr Hafiz Muhammad Ali, The Islamia University of Bahawalpur, Bahawalpur, Pakistan

Assist. Prof. Dr. Hafiz Muhammad Ali is an esteemed researcher in cell and molecular biology, veterinary sciences, and biotechnology 🧬🔬. His groundbreaking work focuses on deciphering molecular mechanisms behind diseases and advancing therapeutic solutions 💊. With over a decade of research and teaching experience, he has significantly contributed to academia 📚 and innovation. His publications in high-impact journals and numerous accolades, including PhD thesis awards, scholarships, and merit certificates, highlight his academic excellence 🏅. His ability to bridge molecular biology and veterinary sciences makes him a strong candidate for the Best Researcher Award. Dr. Ali’s work extends globally, with collaborations in France and Pakistan, ensuring a deep scientific impact 🌍. His research on natural therapeutics, disease pathology, and molecular interventions is vital for medical and veterinary advancements. A dedicated academician and researcher, he continues to inspire future scientists with his passion and innovation 🚀.

Publication Profile

Scopus

Education

Dr. Hafiz Muhammad Ali holds an exceptional academic background with degrees from prestigious institutions across France and Pakistan 🌍. He earned his PhD in Cell and Molecular Biology from Institut Gustave Roussy, France 🧬, where he specialized in disease pathology and therapeutic development. His Master 2 Research in Cell Biology from CNRS – University Denis Diderot Paris-7 strengthened his expertise in molecular cell dynamics and disease models 🏥. Prior to that, he completed a (Hons.) degree in Veterinary Anatomy from University of Agriculture, Faisalabad, Pakistan 🐾. His academic journey is marked by unparalleled dedication and excellence, receiving multiple scholarships and research grants 🏆. His education laid the foundation for pioneering research in molecular mechanisms linked to veterinary and biomedical sciences. Through rigorous training and international collaborations, Dr. Ali has established himself as a leading expert in cell and molecular biology 🔬.

Experience

Dr. Ali has accumulated over 10 years of research and teaching experience across France and Pakistan 🌍. He serves as an Assistant Professor (TTS) at The Islamia University of Bahawalpur, where he mentors students and conducts high-impact research 🎓. His international experience includes working as a Researcher/Biologist at UMR 8203 CNRS, Villejuif, France, where he investigated molecular pathways in disease development and therapy 🧬. His expertise spans cellular biology, veterinary sciences, and biotechnology, contributing to scientific breakthroughs and fostering global research collaborations 🤝. Dr. Ali has been instrumental in developing novel therapeutic strategies, integrating in vitro, in vivo, and in silico methodologies 💊. His contributions to academia and scientific innovation make him a renowned expert in his field. With a strong publication record and impactful research, Dr. Ali continues to shape the future of biomedical and veterinary sciences 🚀.

Awards and Honors

Dr. Hafiz Muhammad Ali’s outstanding contributions have earned him prestigious awards and recognitions 🏅. He received a PhD Thesis Award for his groundbreaking work in cell and molecular biology 🔬. His academic excellence was acknowledged through multiple PhD scholarships, university merit scholarships, and shields for research excellence 🏆. Additionally, he has received appreciation certificates for his significant contributions to biotechnology and veterinary sciences 🐾. His international recognition includes accolades for research excellence in France and Pakistan, highlighting his global impact 🌍. Dr. Ali’s unwavering dedication to scientific advancements has placed him among the leading researchers in his domain. His achievements underscore his commitment to pushing scientific boundaries and mentoring future researchers 🎓. These accolades solidify his reputation as a trailblazer in molecular biology and veterinary research, making him a deserving candidate for the Best Researcher Award 🏅.

Research Focus

Dr. Ali’s research revolves around molecular biology, cell biology, and veterinary sciences 🧬. His primary focus is to unravel molecular mechanisms underlying diseases and develop novel therapeutic strategies 💊. He explores disease pathophysiology, with an emphasis on cell signaling, genetic expressions, and natural bioactive compounds 🌿. His biomedical and veterinary research integrates advanced molecular techniques, computational biology, and experimental therapeutics 🏥. He is particularly interested in natural product-based drug discovery, bridging the gap between traditional medicine and modern therapeutics 🌿🩺. His international collaborations have enabled multidisciplinary research, focusing on disease modeling and translational medicine 🏥. By leveraging state-of-the-art molecular biology tools, Dr. Ali aims to advance precision medicine and targeted therapies 🎯. His research contributes to both human and animal health, making him a pioneer in molecular and veterinary sciences 🚀.

Publication Top Notes

📄 Estimation of median LC50 and toxicity of environmentally relevant concentrations of thiram in Labeo rohita – Assist. Prof. Dr. Hafiz Muhammad Ali et al., npj Clean Water, 2025 (📑 0 citations)

🔬 Search for Magnetic Monopole Pair Production in Ultraperipheral Collisions at the LHC – J. Gallagher et al., Physical Review Letters, 2025 (📑 0 citations)

🧪 Constraint on the total width of the Higgs boson from Higgs boson and four-top-quark measurements in pp collisions at s = 13 TeV – G. Aad et al., Physics Letters B, 2025 (📑 1 citation)

⚛️ Combination of searches for singly produced vectorlike top quarks in collisions at the LHC – J. Gallagher et al., Physical Review D, 2025 (📑 0 citations)

🌀 Measurement of top-quark pair production in association with charm quarks in proton–proton collisions at s=13 TeV – G. Aad et al., Physics Letters B, 2025 (📑 0 citations)

🔋 Combination of searches for singly and doubly charged Higgs bosons produced via vector-boson fusion in proton–proton collisions at s=13 TeV – G. Aad et al., Physics Letters B, 2025 (📑 0 citations)

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Published on 07/03/202507/03/2025 by Research Hypothesis

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Dr VIVEKANAND ASHOK, Azeezia Health City, India

Dr. Vivekanand Ashok is a dedicated otorhinolaryngologist with a passion for research and surgical excellence. His extensive work spans cochlear implants, otologic surgeries, and head and neck disorders. With numerous high-impact publications in esteemed journals, his research has significantly contributed to advancements in ENT care. His clinical expertise in endoscopic sinus surgery, thyroid disorders, and voice disorders, combined with his academic contributions, makes him a deserving candidate for the Best Researcher Award. His continuous pursuit of innovation in ENT treatments, active participation in conferences, and commitment to medical education further solidify his reputation as an outstanding researcher. 🏅📚🔬

Publication Profile

Orcid

Education

Dr. Vivekanand Ashok 🎓 pursued his MBBS from Azezia Institute of Medical Sciences, Kerala (2014) 🏥📖, followed by an M.S in ENT from Bangalore Medical College and Research Institute, Karnataka (2020) 🎓🩺. He further obtained a DNB (ENT) in 2021 🏅📚 and completed a Fellowship in Cochlear Implant Surgery at GMERS Gandhinagar in 2023 🎧🔬. With a strong foundation in otorhinolaryngology, he specializes in ENT surgeries and cochlear implants, demonstrating his dedication to patient care. His rigorous training at top institutions has equipped him with expertise in handling complex ENT cases, establishing him as a leader in the field. 📘💉🔍

Experience

Dr. Vivekanand Ashok is a distinguished ENT specialist with extensive experience in medical education, clinical practice, and research. He served as a Senior Resident at Karnataka Institute of Medical Sciences (2020-2021) 🏨👨‍⚕️ and Malabar Cancer Centre, Kerala (2021-2022) 🎗️🏥, honing his expertise in otolaryngology. Transitioning into academia, he worked as an Assistant Professor at Karuna Medical College, Kerala (2022-2024) 🎓📖, shaping future medical professionals. Currently, he excels as a Senior Consultant at Co-operative Hospital, Kattappana (2024-2025) 🏨🩺 and Azeezia Health City, Palakkad (2025-Present) ⚕️🔬. His dedication to patient care and surgical excellence makes him a respected figure in the field. 🏆👨‍⚕️

Awards & Honors

Dr. Vivekanand Ashok’s dedication to academic excellence and research has earned him prestigious accolades in the field of ENT. He secured 3rd position in the South Zone ENT Quiz (2018) 🥉🧠, demonstrating his deep knowledge and expertise. In 2019, he was a Zonal Round Participant in the South Zone Young Scholar Award 🎖️📖, further highlighting his commitment to continuous learning and professional growth. These achievements reflect his passion for advancing medical knowledge and contributing to the field of otolaryngology. Through his dedication to research and education, Dr. Ashok continues to make a significant impact in the medical community. 🏆🔬

Research Focus

Dr. Ashok specializes in otorhinolaryngology, cochlear implants, head and neck surgery, and otologic diseases. His research focuses on laryngopharyngeal reflux, rhino-orbital mucormycosis, thyroid carcinomas, and nasal hemangiomas. His work has contributed to improving diagnostic techniques and treatment approaches in ENT disorders. With a passion for innovation, he continues to explore advancements in hearing restoration, sinus surgery, and minimally invasive ENT procedures. 🎧👂📊